Price (delayed)
$255.33
Market cap
$9.89B
P/E Ratio
232.12
Dividend/share
N/A
EPS
$1.1
Enterprise value
$9.73B
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses
There are no recent dividends present for PEN.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.